XV Konferencja Naukowa Polskiego Towarzystwa Hepatologicznego
News
Current issue
Archival Issues
Search
Newsletter
Manuscript Submission
 » 
Journal Abstract
 
Entecavir (Baraclude) and pegylated interferon alfa-2a (Pegasys) – New treatment options in chronic hepatitis B in Poland
Waldemar Halota, Małgorzata Pawłowska
Medical Science Review - Hepatologia 2007; 7 25-28
aaICID: 485980
Article type: Review article
IC™ Value: 2.88
Abstract provided by Publisher
 
Authors present the results of studies confirmed that entecavir and pegylated interferon alfa-2a are the attractive treatment options in chronic hepatitis B. Recently both these drugs have been registered in Poland and included in Consensus of CHB Treatment.

ICID 485980
 
FULL TEXT 67 KB


Related articles
  • in IndexCopernicus™
         leczenie immunosupresyjne [7 related records]
         pegylowany interferon alfa-2a [1 related records]
         entekawir [1 related records]


  •  

    Copyright © Medical Science Review - Hepatologia  2017
    Page created by Index Copernicus Ltd. All Rights reserved.